Cite
HARVARD Citation
Kobashigawa, J. et al. (2013). Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. Transplant infectious disease. 15 (2), pp. 150-162. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kobashigawa, J. et al. (2013). Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. Transplant infectious disease. 15 (2), pp. 150-162. [Online].